Clara cell secretory protein (CC16): possibility of detection in exhaled breath condensate
C. Vogelberg, S. Ruß, K. Marx, A. Böhm, A. Rösen-Wolff (Dresden, Germany)
Source: Annual Congress 2007 - Noninvasive evaluation of airway diseases
Session: Noninvasive evaluation of airway diseases
Session type: Electronic Poster Discussion
Number: 528
Disease area: Airway diseases
Abstract Clara cell secretory protein (CC16) is secreted by Clara cells and has antiinflammatory properties within the lung. It seems to be a marker for airway epithelial injury. While increased levels of CC16 were found in broncho-alveolar lavage fluid (BALF) of patients with acute respiratory distress syndrome, reduced levels of CC 16 have been found in BALF of smokers, patients with lung cancer, COPD or asthma. The aim of the study presented was to determine whether CC16 can be measured in exhaled breath condensate and whether levels of CC16 differentiate between asthmatics and healthy controls. Breath condensate was sampled from 15 healthy adults during 10 min of relaxed tidal breathing with a commercially available condenser (EcoScreen, JAEGER). CC16 was analysed with an ELISA (BioVendor Laboratory Medicine, Inc.) before and after lyophilisation of the sample. Further the recovery rate of the positive control within the breath condensate was analysed. CC16 was neither detectable in the native nor in the lyophilized samples. The recovery rate of CC16 positive controls within exhaled breath condensate was good (min. 4,39 ng/ml). The present study results suggest that exhaled breath condensate analysis is not a suitable method for detection of CC16. One reason for this might be because of concentrations below detection limit of CC16 within the condensate. This again might be due to the peripheral localisation of the clara cells within the airways.
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Vogelberg, S. Ruß, K. Marx, A. Böhm, A. Rösen-Wolff (Dresden, Germany). Clara cell secretory protein (CC16): possibility of detection in exhaled breath condensate. Eur Respir J 2007; 30: Suppl. 51, 528
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Protein pattern of exhaled breath condensate (EBC) and saliva Source: Eur Respir J 2001; 18: Suppl. 33, 461s Year: 2001
Human skin keratins are the major proteins in exhaled breath condensate Source: Eur Respir J 2008; 31: 380-384 Year: 2008
Keratin detected in exhaled breath condensate is an environmental contaminant Source: Annual Congress 2005 - Airway epithelial cells in asthma and COPD Year: 2005
Breath condenser coatings affect measurement of biomarkers in exhaled breath condensate Source: Eur Respir J 2006; 28: 1036-1041 Year: 2006
Protein markers in the exhaled breath condensate of lung carcinoma patients Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012
The concentration of total protein in exhaled breath condensate (EBC) depends on various variables of ventilation Source: Eur Respir J 2006; 28: Suppl. 50, 283s Year: 2006
Alpha-1-antitrypsin is detectable and can be quantified in exhaled breath condensate Source: Annual Congress 2008 - New frontiers in noninvasive assessment of the lungs Year: 2008
The coating of condenser systems influences the detection of 8-isoprostane in exhaled breath condensate (EBC) Source: Eur Respir J 2004; 24: Suppl. 48, 468s Year: 2004
Airway cytokine expression measured by protein array in exhaled breath condensate: correlation with physiological properties in asthmatic patients Source: Eur Respir J 2006; 28: Suppl. 50, 444s Year: 2006
Clara cell protein (CC16) as a biomarker for ozone exposure in humans Source: Eur Respir J 2002; 20: Suppl. 38, 569s Year: 2002
Separate lung exhaled breath condensate collection confirms intrapulmonary origin of exhaled breath condensate acidification Source: Eur Respir J 2007; 30: Suppl. 51, 364s Year: 2007
Exhaled breath condensate pH is a robust and reproducible assay of airway acidity Source: Eur Respir J 2003 Dec 01;22(6):889-894 Year: 2003
Detection and variability of cytokine-levels in exhaled breath condensate (EBC) of patients with stable COPD Source: Eur Respir J 2003; 22: Suppl. 45, 438s Year: 2003
Proteins in exhaled breath condensate: identification and pattern Source: Annual Congress 2007 - Noninvasive evaluation of airway diseases Year: 2007
Detection of ProGRP and NSE in exhaled breath condensate (EBC) of patients with SCLC and NSCLc Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs Year: 2008
Relationships between the concentrations of NO, IL1β, TNF-α, IL-6 in exhaled breath condensate (EBC) and lung function in patient with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 61s Year: 2005
Validation of assays for inflammatory mediators in exhaled breath condensate Source: Eur Respir J 2008; 31: 943-948 Year: 2008
Adenosine levels in the exhaled breath condensate: a potential surrogate marker of airway inflammation Source: Eur Respir J 2003; 22: 392 Year: 2003
Nitrite concentration in exhaled breath condensate correlates with markers of lung overdistension in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 317s Year: 2004
Exhaled breath condensate pH standardised for CO2 partial pressure Source: Eur Respir J 2007; 29: 496-501 Year: 2007